5 Points to Consider when Evaluating your CMO’s Analytical Capabilities

Posted: March 23, 2018

API Manufacturing and Pharmaceutical Manufacturing




Part 3 of our “How to Select a CMO” Video Series
View all the videos in the series »

Related posts:

Life Science Leader - Louis Gargulio - PCI Synthesis
PCI Synthesis at DCAT Week 2017
Top Early Stage Method Validation Mistakes and How to Avoid Them
Cryogenic API Manufacturing
DEA Controlled Substance API manufacturing

About the Author

Ed Price CEO of PCI Synthesis
Ed is the President and CEO of PCI Synthesis (PCI), he serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA).

Do you have questions? Talk to Ed.